Dexamethasone Injection Dexamethasone Injection (1 mL Vial) commercial product Product Overview Dexamethasone is a potent, long-acting synthetic fluorinated glucocorticoid first described in the late 1950s and adopted for parenteral therapy soon afterward
Steroids decrease the production of inflammatory chemicals and reduce the sensitivity of nerve fibers to pain, generating fewer pain signals
Collectively the EARs, RDAs, AIs, and ULs are referred to as dietary reference intakes (DRIs)
However, GLP-1 agonists have limitations
It is an unapproved investigational compound that did not complete clinical development, has not been authorized by Health Canada for any human or veterinary indication, and is not intended to diagnose, treat, cure, or prevent any disease
Final treatment options and eligibility should be reviewed by your provider during your appointment.